Literature DB >> 9801846

Ovarian cancer: an update on genetics and therapy.

R T Penson1, K E Shannon, N E Sharpless, M V Seiden.   

Abstract

This article reviews the important aspects of the management of both early and advanced ovarian cancer with a particular emphasis on genetic predisposition and recent and anticipated advances in treatment.

Entities:  

Mesh：

Year:  1998        PMID： 9801846

Source DB:  PubMed          Journal:  Compr Ther        ISSN： 0098-8243


  4 in total

1.  Case Report-Loyalty, Legacy, and Ledger: Contextual Therapy in a Patient with a Family History of Ovarian Cancer.

Authors:  T C Brown; J Garber; M Muto; K A Schneider
Journal:  J Genet Couns       Date:  1999-12       Impact factor: 2.537

2.  Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer.

Authors:  H Yagi; S Miyamoto; Y Tanaka; K Sonoda; H Kobayashi; T Kishikawa; R Iwamoto; E Mekada; H Nakano
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

3.  Role of NSC319726 in ovarian cancer based on the bioinformatics analyses.

Authors:  Ji Xue; Guang Yang; Hong Ding; Pu Wang; Changhong Wang
Journal:  Onco Targets Ther       Date:  2015-12-15       Impact factor: 4.147

4.  Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers.

Authors:  Eliane Duarte-Franco; Eduardo L Franco
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.